Mini Oral Abstract SessionMA11.07 Improved Small Cell Lung Cancer (SCLC) Response Rates with Veliparib and Temozolomide: Results from a Phase II Trial
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2016 Published by Elsevier Inc.